Results
Corona Remedies Reports 17% FY26 Revenue Growth to ₹1,403 Cr
Corona Remedies delivered strong FY25-26 performance with 17.28% revenue growth to ₹1,403.18 Cr and 33.45% PAT growth to ₹199.42 Cr, significantly outperforming IPM growth of 8.59%.
The company succes
